← back to search

Victor Lee

Queen Mary Hospital ·
Area of research
Otorhinolaryngology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, and Cancer Immunotherapy and Biomarkers.
h-index
57
citations
11,251
works
660
NIH funding
primary concept
Medicine
email

Recent publications

International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
International Journal of Radiation Oncology*Biology*Physics 2025cited by 12position: middledoi
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies
Clinical Cancer Research 2025cited by 10position: middledoi
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab
Journal of Clinical Oncology 2025cited by 9position: middledoi
Developing a named entity framework for thyroid cancer staging and risk level classification using large language models
npj Digital Medicine 2025cited by 9position: middledoi
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
The Lancet Oncology 2025cited by 7position: middledoi
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification
JAMA Oncology 2024cited by 96position: middledoi
Stereotactic Body Radiotherapy and Liver Transplant for Liver Cancer
JAMA Network Open 2024cited by 17position: firstdoi
Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis
Radiotherapy and Oncology 2024cited by 12position: middledoi
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors
International Forum of Allergy & Rhinology 2023cited by 120position: middledoi
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
Nature Communications 2023cited by 67position: middledoi
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
The Lancet Oncology 2023cited by 67position: middledoi
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions
Journal of Clinical Oncology 2023cited by 55position: middledoi
Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC
Hepatology 2023cited by 38position: middledoi
Radiomic feature repeatability and its impact on prognostic model generalizability: A multi-institutional study on nasopharyngeal carcinoma patients
Radiotherapy and Oncology 2023cited by 32position: middledoi
Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management – A Systematic Review
Dove Medical Press (Taylor and Francis Group) 2022cited by 24position: middle
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study
EClinicalMedicine 2022cited by 11position: middledoi
Quantitative Spatial Characterization of Lymph Node Tumor for N Stage Improvement of Nasopharyngeal Carcinoma Patients
Cancers 2022cited by 7position: middledoi
Cardiovascular diseases among diffuse large B-cell lymphoma long-term survivors in Asia: a multistate model study
ESMO Open 2022cited by 6position: firstdoi
Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
Nature Communications 2021cited by 211position: middledoi
A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma
European Journal of Cancer 2021cited by 95position: middledoi
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Clinical Cancer Research 2021cited by 57position: middledoi
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
Clinical and Translational Radiation Oncology 2021cited by 44position: middledoi
Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
Annals of Translational Medicine 2021cited by 2position: middledoi
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
Journal of Hepatology 2020cited by 187position: middledoi
An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective
Radiotherapy and Oncology 2020cited by 50position: middledoi
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies
Lung Cancer 2018cited by 47position: middledoi
Association between GWAS-identified lung adenocarcinoma susceptibility loci and<i>EGFR</i>mutations in never-smoking Asian women, and comparison with findings from Western populations
Human Molecular Genetics 2016cited by 67position: middledoi
Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women
Human Molecular Genetics 2016cited by 56position: middledoi
Direct observation of particle interactions and clustering in charged granular streams
Nature Physics 2015cited by 135position: firstdoi
Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells
Gastroenterology 2015cited by 60position: middledoi

Grants

EAGER: MAKER: Tracking Youth Interest and Engagement in Makerspace Learning Activities Using Wearable Technology
NSF1949740$22,7652019–2020PIRePORTER
EAGER: MAKER: Tracking Youth Interest and Engagement in Makerspace Learning Activities Using Wearable Technology
NSF1623401$299,9112016–2019PIRePORTER

Frequent collaborators

Anne W.M. Lee · The University of Texas MD Anderson Cancer Center3 papers (2021–2024)Alfio Ferlito · University of Turku3 papers (2021–2024)Wai Tong Ng · Chinese University of Hong Kong3 papers (2021–2024)Xin‐Yuan Guan · Chongqing Jiaotong University3 papers (2012–2023)Wen-Yen Huang · National Yang Ming Chiao Tung University2 papers (2020–2020)Jinlin Huang · Geisinger Medical Center2 papers (2021–2023)Andy Lai-Yin Cheung · Sun Yat-sen University Cancer Center2 papers (2022–2023)Beilei Liu · City University of Hong Kong2 papers (2021–2023)Ka-On Lam · Amgen (United States)2 papers (2021–2024) · 2 papers (2012–2021)Jason Chia‐Hsien Cheng · Hainan Medical University2 papers (2020–2020)Juan P. Rodrigo · San Francisco General Hospital2 papers (2021–2022)Lanqi Gong · New York University2 papers (2021–2023)Francis Kar-Ho Lee · Sun Yat-sen University Cancer Center2 papers (2022–2023) · 2 papers (2020–2020)Xinzhi Teng · Hong Kong Polytechnic University2 papers (2022–2023)Nabil F. Saba · Emory University2 papers (2021–2022)Saikit Lam · Sun Yat-sen University Cancer Center2 papers (2022–2023)Baifeng Zhang · Ningbo University2 papers (2021–2023)Xiaona Fang · Sun Yat-sen University2 papers (2021–2023)